Reuters logo
10 months ago
BRIEF-BioPorto files pre-sub application for NGAL test to FDA
October 10, 2016 / 8:06 AM / 10 months ago

BRIEF-BioPorto files pre-sub application for NGAL test to FDA

Oct 10 (Reuters) - BioPorto A/S

* Files pre-sub application for the NGAL test to FDA

* Maintains expectation that approval can be obtained by mid-2018

* Says enrollment of patients is expected to commence in Q2 2017

* Financial outlook for 2016 is maintained Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below